期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

慢性肾脏病与心脑血管疾病 被引量：6

原文传递
导出
摘要 慢性。肾脏病（CKD）是心血管疾病（CVD）发生、发展的独立危险因素。对于普通人群，CKD可明显增加CVD发生的风险；对于已有CVD或存在CVD危险因素的人群，CKD则可明显增加心血管事件如卒中、急性心肌梗死、心功能不全等的发生。另一方面，CVD又是促进CKD进展、影响CKD预后的重要因素，也是导致CKD患者致残、致死的第一位常见原因。
作者 周秋根 侯凡凡
机构地区 南方医科大学南方医院肾内科
出处 《中华内科杂志》 CAS CSCD 北大核心 2008年第11期886-888,共3页 Chinese Journal of Internal Medicine
关键词 慢性肾脏病 心脑血管疾病 独立危险因素 急性心肌梗死 普通人群 心血管疾病 CKD 心血管事件
分类号 R686 [医药卫生—骨科学]
  • 相关文献

参考文献19

  • 1Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease : a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation, 2003, 108 : 2154-2169.
  • 2Weiner DE, Tabatabai S, Tighiouart H, et al. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis, 2006, 48: 392-401.
  • 3Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol, 2003, 41: 47-55.
  • 4Arnlov J, Evans JC, Meigs JB, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals : the Framingham Heart Study. Circulation, 2005, 112: 969-975.
  • 5Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation, 2002, 106 : 1777-1782.
  • 6Shlipak MG, Heideureich PA, Noguchi H, et al. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med, 2002, 137: 555- 562.
  • 7Rubenstein MH, HarreU LC, Sheynberg BV, et al. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation, 2000, 102: 2966- 2972.
  • 8侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J].中华医学杂志,2005,85(7):458-463. 被引量：183
  • 9Stuveling EM, HiUege HL, Bakker SJ, et al. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int, 2003, 63 : 654-661.
  • 10Hotamisligil GS. Inflammation and metabolic disorders. Nature, 2006, 444: 860-867.

二级参考文献28

  • 1侯凡凡.慢性肾脏病的心血管并发症[J].中华心血管病杂志,2004,32:16-16.
  • 2何长民 张训 见:何长民 张训主编.前言[A].见:何长民,张训主编.肾脏替代治疗学[C].上海:上海科学技术文献出版社,1999．2..
  • 3Locatelli F, Pozzoni P, Tentori F, et al. Epidemiology of cardiovascular risk in patients with chronic kidney disease. Nephrol Dial Transplant, 2003,18 Suppl 7:2-9.
  • 4Muntner P, He J, Hamm L, et al. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol, 2002,13:745-753.
  • 5Manjunath G, Tighiouart H, Ibrahim H, et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol, 2003,41:47-55.
  • 6Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int, 1995,47:186-192.
  • 7Sarnak MJ, Levey AS, Schoolwerth AC,et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation, 2003,108:2154-2169.
  • 8Foley RN, Herzog CA, Collins AJ. Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 Study. Kidney Int, 2003,63:1462-1467.
  • 9Wong JS, Rort FK, Hulbert-Shearon TE, et al. Survival advantage in Asian American end-stage renal disease patients. Kidney Int, 1999,55:2515-2523.
  • 10Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998,32:s112-s119.

共引文献221

同被引文献48

  • 1生杰,赵久阳.慢性肾脏病患者钙磷代谢紊乱与心瓣膜钙化[J].中国血液净化,2012,11(2):99-101. 被引量：13
  • 2侯凡凡,马志刚,梅长林,戎殳,黄颂敏,刘先蓉,袁伟杰,郭云珊,王莉,何强,王秀玲,桑晓红,栗霄立.中国五省市自治区慢性肾脏病患者心血管疾病的患病率调查[J].中华医学杂志,2005,85(7):458-463. 被引量：183
  • 3Silverberg D S, Wexler D, Blum M, et al. The use of subctaneous erythropoietin and intravenous iron for the treament of the anemia of severe, resistant congestive heart failure improves cardio and renal function and functional cardio class, and markedly reduces hospitalization[J]. J Am Coll Cardiol, 2000,35 : 1737-- 1744.
  • 4Gilbertson D,Li S,Murray A M,et al . Competing risks of death vs ESRD in medicare beneficiaries age 65 with chronic kidney disease CHF and anemia[J]. J Am Soc Nephrol, 2002,13 : SA848.
  • 5Silverberg D S, Wexler D, Iaina A, et al. Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists[J].Int UrolNephrol, 2006,38(2):295--310.
  • 6Tsuruya K, Hirakata H. Anemia as a risk fator for CKD and CVD [J].Nippon Rinsho,2008,66(9):1786-1793.
  • 7Efstratiadis G, konstantinou D, Chytas I, et al. Cardio--renal syndrone[J]. Hippkratia, 2008,12 (1) : 11 -- 16.
  • 8Comin--Colet J,Ruiz S, Cladellas M, et al. A pilot evaluation of the long-- term effect of combined therapy with intravenous iron sucrose and erythropoietin in elderly patients with advanced chronic heart failure and cardio--renal anemia syndrome: influence on neurohormonal activation and clinical outcomes[J].J Card Fail,2009 , 15(9) :727--735.
  • 9Hooi J D,Kester A D,Stoffers H E,et al.Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study[J].J Clin Epidemiol,2004,57 (3):294-300.
  • 10Go A S,Chertow G M,Fan D,et al.Chronic kidney disease and the risks of death,cardiovascular events,and hospitalization[J].N Engl J Med,2004,351 (13):1296-1305.

引证文献6

二级引证文献28

中华内科杂志
2008年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部